Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2013-06-13 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LES BROUZILS (85260), Vendee
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DES BROUZILS : revenue, balance sheet and financial ratios
SARL PHARMACIE DES BROUZILS is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LES BROUZILS (85260),
this company of category PME
shows in 2024 a net income positive of 59 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DES BROUZILS (SIREN 793621590)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
58 846 €
61 550 €
90 607 €
90 538 €
62 838 €
63 017 €
59 642 €
65 019 €
46 324 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SARL PHARMACIE DES BROUZILS generates positive net income of 59 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 46 k€ -> 59 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
58 846 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 39%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
38.949%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.447%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DES BROUZILS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.0
415.79
297.669
214.274
156.497
108.217
72.471
52.709
38.949
Financial autonomy
12.772
18.048
23.469
29.37
35.849
42.702
51.799
57.049
62.447
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
38.952024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-10 pts over 3 years
In 2024, the debt ratio of SARL PHARMACIE DES BROUZILS (38.95) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
62.45%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+10 pts over 3 years
In 2024, the financial autonomy of SARL PHARMACIE DES BROUZILS (62.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 149.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
149.823
Liquidity indicators evolution SARL PHARMACIE DES BROUZILS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
379.403
296.66
297.696
255.374
234.049
193.09
184.539
159.829
149.823
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
149.822024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average-8 pts over 3 years
In 2024, the liquidity ratio of SARL PHARMACIE DES BROUZILS (149.82) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SARL PHARMACIE DES BROUZILS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SARL PHARMACIE DES BROUZILS is estimated at
821 533 €
(range 572 103€ - 1 229 061€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
572k€821k€1229k€
821 533 €Range: 572 103€ - 1 229 061€
NAF 5 année 2024
Valuation method used
Net Income Multiple
58 846 €
×
14.0x
=821 534 €
Range: 572 103€ - 1 229 061€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DES BROUZILS with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DES BROUZILS
What is the revenue of SARL PHARMACIE DES BROUZILS ?
The revenue of SARL PHARMACIE DES BROUZILS is not publicly disclosed (confidential accounts filed with INPI).
Is SARL PHARMACIE DES BROUZILS profitable?
Yes, SARL PHARMACIE DES BROUZILS generated a net profit of 59 k€ in 2024.
Where is the headquarters of SARL PHARMACIE DES BROUZILS ?
The headquarters of SARL PHARMACIE DES BROUZILS is located in LES BROUZILS (85260), in the department Vendee.
Where to find the tax return of SARL PHARMACIE DES BROUZILS ?
The tax return of SARL PHARMACIE DES BROUZILS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DES BROUZILS operate?
SARL PHARMACIE DES BROUZILS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart